Ionis Pharma Urges Investors to Reject the Below-the-Market Offer By Post author:Sam Post published:August 23, 2017 Post category:BioPharma August 24, 2017By Mark Terry… Source: BioSpace You Might Also Like Incyte Discloses Promising New Data in Combo Drug Trial With Merck & Co.'s Keytruda August 30, 2017 Gilead's Kite Pays $135M for Ex-Agensys R&D Building January 22, 2018 This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG May 7, 2017
